Yale fibrosis drug may offer new treatment path for COVID-19 lung distress
The drug sobetirome shows promise in preventing and treating Acute Respiratory Distress Syndrome — a life-threatening condition common in COVID-19 patients.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: COVID-19 | Health | Respiratory Medicine | Science | Universities & Medical Training | Yale